VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
- Revenue, 2025
- $517M
- YoY, 2025
- +16.0%
- 5-year CAGR
- +34.5%
- 10-year CAGR
- +26.4%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $517M | +16.0% |
| 2024 | $446M | +23.5% |
| 2023 | $361M | +21.8% |
| 2022 | $297M | +35.1% |
| 2021 | $220M | +86.8% |
| 2020 | $117M | −2.4% |
| 2019 | $120M | +30.8% |
| 2018 | $92M | +27.9% |
| 2017 | $72M | +10.6% |
| 2016 | $65M | +31.5% |
| 2015 | $50M | +29.6% |
| 2014 | $38M | +74.5% |
| 2013 | $22M | +88.2% |
| 2012 | $12M | +339.6% |
| 2011 | $2.6M | — |